Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gabriela Guillen Burrieza"'
Autor:
Andrea Ferrari, Bernadette Brennan, Michela Casanova, Nadege Corradini, Pablo Berlanga, Reineke A Schoot, Gema L Ramirez-Villar, Akmal Safwat, Gabriela Guillen Burrieza, Patrizia Dall'Igna, Rita Alaggio, Lisa Lyngsie Hjalgrim, Susanne Andrea Gatz, Daniel Orbach, Max M van Noesel
Publikováno v:
Ferrari, A, Brennan, B, Casanova, M, Corradini, N, Berlanga, P, Schoot, R A, Ramirez-Villar, G L, Safwat, A, Burrieza, G G, Dall’igna, P, Alaggio, R, Hjalgrim, L L, Gatz, S A, Orbach, D & van Noesel, M M 2022, ' Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas : Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) ', Cancer Management and Research, vol. 14, pp. 2885-2902 . https://doi.org/10.2147/CMAR.S368381
This paper describes the standard of care for patients with non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) and the therapeutic recommendations developed by the European paediatric Soft tissue sarcoma Study Group (EpSSG). NRSTS form a very mixed gr
Autor:
Pablo Berlanga, Daniel Orbach, Reineke A. Schoot, Michela Casanova, Rita Alaggio, Nadege Corradini, Bernadette Brennan, Gema L. Ramirez‐Villar, Lisa Lyngsie Hjalgrim, Julia C. Chisholm, Gianni Bisogno, Beatrice Coppadoro, Akmal Safwat, Johannes H. M. Merks, Gabriela Guillen Burrieza, Max M. van Noesel, Andrea Ferrari
Publikováno v:
Pediatric Blood & Cancer.
Autor:
Andrea Ferrari, Daniel Orbach, Michela Casanova, Max M. van Noesel, Pablo Berlanga, Bernadette Brennan, Nadege Corradini, Reineke A. Schoot, Gema L. Ramirez‐Villar, Lisa Lyngsie Hjalgrim, Rita Alaggio, Gabriela Guillen Burrieza, Akmal Safwat, Alison L. Cameron, Rick R. van Rijn, Veronique Minard‐Colin, Ilaria Zanetti, Gianni Bisogno, Julia C. Chisholm, Johannes H. M. Merks
Publikováno v:
Cancer. John Wiley and Sons Inc.
Background: Limited data exist on the clinical behavior of pediatric non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) with distant metastases at onset, and a clear standard of care has not yet been defined. Methods: This cohort study reports on pedi
Autor:
Gabriel Gallo-Oller, Guillem Pons, Júlia Sansa-Girona, Natalia Navarro, Patricia Zarzosa, Lia García-Gilabert, Paula Cabré-Fernandez, Gabriela Guillén Burrieza, Lorena Valero-Arrese, Miguel F. Segura, José M. Lizcano, José Sánchez de Toledo, Lucas Moreno, Soledad Gallego, Josep Roma
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-5 (2024)
Abstract Rhabdomyosarcoma (RMS), such as other childhood tumors, has witnessed treatment advancements in recent years. However, high-risk patients continue to face poor survival rates, often attributed to the presence of the PAX3/7-FOXO1 fusion prote
Externí odkaz:
https://doaj.org/article/cf85de5b09dc4dea93dd0e8051e90a69